Ruxolitinib-Treated Myeloproliferative Neoplasms: Real-World Infectious Outcomes and Preventive Practices from a Single Center. (2026). Mediterranean Journal of Hematology and Infectious Diseases, 18(1). https://doi.org/10.4084/MJHID.2026.044